谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Phase I/II Results of Ceralasertib As Monotherapy or in Combination with Acalabrutinib in High-Risk Relapsed/refractory Chronic Lymphocytic Leukemia

Wojciech Jurczak,Nagah Elmusharaf,Christopher P. Fox,William Townsend,Amanda G. Paulovich,Shringi Sharma,Graeme Parr,Veerendra Munugalavadla,Fanny Krantz,Helen Yang,Emma Dean,Richa Manwani,Peter Hillmen

Cancer Research（2022）

引用 2|浏览13
关键词
acalabrutinib,ceralasertib,chronic lymphocytic leukemia,molecular targeted therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要